Information Provided By: 
Fly News Breaks for September 15, 2015
ANTH
Sep 15, 2015 | 07:21 EDT
After Anthera announced that Zenyaku has terminated the blisibimod alliance in Japan, Piper Jaffray analyst Edwar Tenthoff reiterates an Overweight rating on the name. While the announcement is a surprise since the deal was only signed last December, all rights to blisibimod return to Anthera at no cost, Tenthoff tells investors in a research note. The analyst viewed the alliance as "little more than a financing vehicle" and assigned no value to blisibimod in Japan in his $14 price target.
News For ANTH From the Last 2 Days
There are no results for your query ANTH
